Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

IMPORTANCE: The optimal treatment approach to patients with acute myeloid leukemia (AML) who relapse after an allogeneic hematopoietic cell transplant (allo-HCT) remains elusive. No randomized clinical trial comparing survival outcomes of a second allo-HCT (allo-HCT2) vs donor lymphocyte infusion (D...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Main Authors: Kharfan-Dabaja, Mohamed A., Labopin, Myriam, Polge, Emmanuelle, Nishihori, Taiga, Bazarbachi, Ali, Finke, Jürgen, Stadler, Michael, Ehninger, Gerhard, Lioure, Bruno, Schaap, Nicolaas, Afanasyev, Boris, Yeshurun, Moshe, Isaksson, Cecilia, Maertens, Johan, Chalandon, Yves, Schmid, Christoph, Nagler, Arnon, Mohty, Mohamad
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2018
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143013/
https://ncbi.nlm.nih.gov/pubmed/30003233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2091
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares